1.Novel nano-drug delivery system for natural products and their application

Huang, Li, Huang, Xu     More...

Huang, Li, Huang, Xue Hua, Yang, Xi, Hu, Jia Qin, Zhu, Yi Zhun, Yan, Pei Yu, Xie, Ying     Less

Pharmacological Research[1043-6618], Published 2024, Volume 201,

收錄情况： SCOPUS

2022影響因子:  9.3 

2.Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer

Xie, Y, Feng, SL, He     More...

Xie, Y, Feng, SL, He, F, Yan, PY, Yao, XJ, Fan, XX, Leung, ELH, Zhou, H     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2022, Volume 186,

收錄情况： WOS

WOS核心合集引用: 4  2022影響因子:  9.3  发表年影響因子:  9.3 

3.Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells

Jiang, ZeBo, Xu, Con     More...

Jiang, ZeBo, Xu, Cong, Wang, Wenjun, Zhang, YiZhong, Huang, JuMin, Xie, YaJia, Wang, QianQian, Fan, XingXing, Yao, XiaoJun, Xie, Chun, Wang, XuanRun, Yan, PeiYu, Ma, YuPo, Wu, QiBiao, Leung, Elaine LaiHan     Less

Pharmacological Research[1043-6618], Published 2021, Volume 169,

收錄情况： WOS SCOPUS

WOS核心合集引用: 8  2022影響因子:  9.3  发表年影響因子:  10.334 

4.Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling

Li, JX, Li, RZ, Sun,     More...

Li, JX, Li, RZ, Sun, A, Zhou, H, Neher, E, Yang, JS, Huang, JM, Zhang, YZ, Jiang, ZB, Liang, TL, Ma, LR, Wang, J, Wang, XR, Fan, XQ, Huang, J, Xie, Y, Liu, L, Tang, L, Leung, ELH, Yan, PY     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2021, Volume 171,

收錄情况： WOS SCOPUS

WOS核心合集引用: 27  2022影響因子:  9.3  发表年影響因子:  10.334